# Jan‐Willem C. Alffenaar

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jan-willem-c-alffenaar/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,679 |
| Field | Tuberculosis Research and Epidemiology |
| h-index | 62 |
| i10-index | 295 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5000820066 |
| ORCID iD | https://orcid.org/0000-0001-6703-0288 |
| Works | 470 |

## Researcher papers

- [Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#](https://scholariq.org/papers/antimicrobial-therapeutic-drug-monitoring-in-critically-ill-adult-patients-a/)
- [Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis](https://scholariq.org/papers/treatment-correlates-of-successful-outcomes-in-pulmonary-multidrug-resistant/)
- [Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study](https://scholariq.org/papers/effectiveness-and-safety-of-bedaquiline-containing-regimens-in-the-treatment-of/)
- [MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network](https://scholariq.org/papers/mdr-xdr-tb-management-of-patients-and-contacts-challenges-facing-the-new-decade/)
- [Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020](https://scholariq.org/papers/worldwide-effects-of-coronavirus-disease-pandemic-on-tuberculosis-services/)
- [Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report](https://scholariq.org/papers/surveillance-of-adverse-events-in-the-treatment-of-drug-resistant-tuberculosis/)
- [Epidemic and pandemic viral infections: impact on tuberculosis and the lung](https://scholariq.org/papers/epidemic-and-pandemic-viral-infections-impact-on-tuberculosis-and-the-lung/)

## Researcher topics

- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology-2/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Mycobacterium research and diagnosis](https://scholariq.org/topics/mycobacterium-research-and-diagnosis/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.